Please enable JavaScript.
Coggle requires JavaScript to display documents.
Infectious Disease - Coggle Diagram
Infectious Disease
-
-
- Respiratory Tract Infections
- Community-Acquired Pneumonia
- Streptococcus pneumoniae (Gram-positive bacteria)
- Most common causative agent
- Haemophilus influenzae (Gram-negative bacteria)
- Atypical Pathogens (Mycoplasma, Legionella)
- Mycoplasma pneumoniae (Atypical)
- Legionella pneumophila (Atypical)
- Infiltrates or consolidation
- Identifies causative bacteria
- Collect sputum sample before antibiotics
- Blood Culture (if severe)
-
- Macrolides (e.g., Azithromycin)
- Effective against atypical pathogens
- Fluoroquinolones (e.g., Levofloxacin)
-
- Beta-lactam antibiotics (if no contraindications)
-
-
- Penicillin G Benzathine (BicillinLA) 24,000 units IM x1
(if Streptococcus pneumoniae is susceptible)
-
- Vancomycin (if MRSA is suspected)
- Methicillin-Resistant Staphylococcus aureus
- Hospital-Acquired Pneumonia (HAP)
- Often Multi-drug Resistant Organisms (e.g., MRSA, Pseudomonas aeruginosa)
- MRSA (Methicillin-Resistant Staphylococcus aureus)
- Pseudomonas aeruginosa (Gram-negative)
- Clinical and Radiological Findings
- New or progressive infiltrates on chest X-ray
- Identifies causative bacteria
- Empirical Antibiotics based on local guidelines
-
-
- De-escalation when culture results available
- Adjust antibiotics based on sensitivity
- Ventilator-Associated Pneumonia (VAP)
- Often Multi-drug Resistant Organisms
- Results from inhaling bacteria from the oropharynx
- Clinical and Radiological Findings
- Lower Respiratory Tract Culture
- Quantitative cultures of bronchial secretions
- Empirical Antibiotics based on local guidelines
- Broad-spectrum antibiotics (e.g., Meropenem, Vancomycin)
- De-escalation when culture results available
- Escherichia coli (Gram-negative bacteria)
- Most common causative agent
- Klebsiella, Enterococcus (less common)
-
- Bacteriuria (bacteria in urine)
- Nitrites, Leukocyte Esterase
-
- Urine Culture (for recurrent or complicated cases)
- Identifies specific bacteria and antibiotic sensitivities
-
- Trimethoprim-sulfamethoxazole
-
- Often Escherichia coli (Gram-negative bacteria)
-
- Nitrites, Leukocyte Esterase
- Blood Culture (if severe or complicated)
-
-
- Skin and Soft Tissue Infections
- Streptococcus pyogenes (Group A Streptococcus, Gram-positive bacteria)
- Staphylococcus aureus (Gram-positive bacteria), including MRSA (Methicillin-Resistant Staphylococcus aureus)
- Erythema, warmth, swelling, pain
- Blood Culture (if severe)
-
-
- Clindamycin (if MRSA is suspected)
- Often Staphylococcus aureus (Gram-positive bacteria), including MRSA
-
- Ultrasound or CT scan (if deep or uncertain diagnosis)
- Locates and measures the abscess
- Incision and Drainage (I&D)
- Surgical procedure to remove pus
- Antibiotics (if systemic signs or severe)
- Trimethoprim-sulfamethoxazole, Doxycycline
- Gastrointestinal Infections
- Viral (e.g., Norovirus, Rotavirus)
-
- Bacterial (e.g., Salmonella, Campylobacter)
-
- Stool Culture (for bacterial causes)
- Identifies specific bacteria
- Presence indicates inflammation
- Supportive Care (hydration)
- Antibiotics (if severe or specific bacterial cause)
- Ciprofloxacin (for severe travelers' diarrhea)
- Azithromycin (for Campylobacter)
- Infection and inflammation of diverticula
- Shows inflammation or abscess
- Ciprofloxacin and Metronidazole
- Often Gardnerella vaginalis (Gram-variable bacteria)
- Microorganism associated with this condition
- Characteristic vaginal discharge (gray, fishy odor)
- Elevated pH is indicative
- Positive test with the addition of KOH
- Epithelial cells with adherent bacteria
- Oral or topical application
-
- Trichomonas vaginalis (Protozoan)
- Parasite causing this STI
- Identifies characteristic motile trichomonads
- Nucleic Acid Amplification Tests (NAAT)
- Highly sensitive and specific
-
- Often caused by Staphylococcus aureus or Streptococcus pyogenes
- Highly contagious skin infection
- Vesicles or pustules that rupture and form honey-colored crusts
- Identifies the causative bacteria
- Topical Antibiotics (Mupirocin)
-
- Oral Antibiotics (Cephalexin)
- For extensive or severe cases
- Opportunistic Infections in HIV
- Various pathogens that take advantage of weakened immune systems in individuals with HIV
- Depends on the specific infection (e.g., Pneumocystis jirovecii pneumonia diagnosed via chest X-ray)
- Antiretroviral Therapy (ART) for HIV to strengthen the immune system
- Specific treatment for the opportunistic infection (e.g., Trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia)
-
- Nucleoside/Nucleotide Analogues
-
- Inhibit viral DNA synthesis by competing with nucleosides
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
-
- Inhibit reverse transcriptase enzyme
-
- Block viral protease enzyme, preventing viral replication
-
- Interfere with viral entry into host cells
-
- Block viral DNA integration into the host genome
- Antiretroviral Drugs (HIV Treatment)
- Combination antiretroviral therapy (cART)
- Uses multiple antiretroviral drugs from different classes to suppress HIV replication
- Pre-exposure Prophylaxis (PrEP)
- Antiretroviral drugs for individuals at high risk of HIV infection
-
- Inhibits fungal cytochrome P450, blocking ergosterol synthesis
- Similar to fluconazole, with broader spectrum
- Inhibits fungal cell wall synthesis by targeting β-glucan
- Binds to ergosterol in fungal cell membranes, causing membrane disruption
- Inhibits fungal ergosterol synthesis
- Candida species (e.g., Candida albicans)
-
- Can affect various body parts (e.g., oral thrush, vaginal candidiasis)
- Opportunistic in immunocompromised individuals
-
- Microscopic examination (if needed)
- Culture (if severe or recurrent)
- Topical or oral antifungals (e.g., Fluconazole)
-
- Often affects the respiratory system
- Invasive pulmonary aspergillosis
- Opportunistic in immunocompromised individuals
- Radiological findings (e.g., chest X-ray, CT scan)
- Serum galactomannan antigen test
-
-
- Liposomal Amphotericin B (if severe)
- Dermatophytosis (Tinea Infections)
- Dermatophyte fungi (e.g., Trichophyton, Microsporum, Epidermophyton)
- Causes skin, hair, and nail infections
- Common infections include athlete's foot, ringworm, and onychomycosis
-
- Microscopic examination (if needed)
- Culture (if severe or recurrent)
- Topical or oral antifungals (e.g., Terbinafine, Fluconazole)
- Dosage and Administration
-
-
-
-